SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-008082
Filing Date
2023-03-17
Accepted
2023-03-17 16:20:17
Documents
16
Period of Report
2023-03-15
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39774
2 ex3-15.htm EX-3.15 2823
3 ex3-15_001.jpg GRAPHIC 213669
4 ex3-15_002.jpg GRAPHIC 755628
5 ex3-15_003.jpg GRAPHIC 363850
  Complete submission text file 0001493152-23-008082.txt   2051201

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ppcb-20230315.xsd EX-101.SCH 3224
7 XBRL LABEL FILE ppcb-20230315_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE ppcb-20230315_pre.xml EX-101.PRE 22357
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3485
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 61-03-9882-0780
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

IRS No.: 300662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-54878 | Film No.: 23742870
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences